Two Cases Show COVID Virus Mutating Around Standard Treatment Remdesivir
WEDNESDAY, Sept. 28, 2022 (HealthDay News) — Patients with weakened immune systems could be inadvertently helping COVID-19 develop resistance to the antiviral drug remdesivir, a new study reports. After lengthy COVID infections, two kidney transplant patients on immune-suppressing drugs to prevent organ rejection developed a mutated version of SARS-CoV-2 resistantContinue Reading